Phase I dose-escalation study of aflibercept in combination with docetaxel and cisplatin in patients with advanced solid tumours
about
Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeuticsUpdate on antiangiogenic therapy in colorectal cancer: aflibercept and regorafenib.Angiogenesis-related pathways in the pathogenesis of ovarian cancerDrug Monographs: Ziv-aflibercept and Vincristine Sulfate Liposome.A phase II multicentre study of ziv-aflibercept in combination with cisplatin and pemetrexed in patients with previously untreated advanced/metastatic non-squamous non-small cell lung cancer.Pharmacokinetic and pharmacodynamic evaluation of aflibercept for the treatment of colorectal cancer.Cell-specific biomarkers and targeted biopharmaceuticals for breast cancer treatment.Phase I dose-escalation study of aflibercept plus docetaxel in nasopharyngeal carcinoma and other solid tumors.Evaluation of bootstrap methods for estimating uncertainty of parameters in nonlinear mixed-effects models: a simulation study in population pharmacokinetics.Population pharmacokinetic analysis of free and bound aflibercept in patients with advanced solid tumors.
P2860
Q26822421-720D20F7-21E7-478D-AB87-F9B96F180F60Q34348270-74EEF9DB-7F15-4536-AE7A-8CE94F434FD9Q37139109-D5DE073C-B078-4D35-AE8C-E4F3CF7D31E2Q37339929-576FEC8F-01B4-422D-A02A-86CBBC1DE186Q37558971-01EF694B-E71A-42DC-9CFC-84886308443BQ38491102-6C3EB9C5-D082-4512-8623-68303DC963D5Q38852051-9C2BB850-A2AD-4496-A6DA-938F39008DF0Q39069493-12894BEA-49B5-442E-B02D-9146BF222C3BQ45358634-D10B17C9-AB18-443C-8F01-F8FC765CF082Q50994490-5A3694F8-50F8-492D-A7FF-E7A465185385
P2860
Phase I dose-escalation study of aflibercept in combination with docetaxel and cisplatin in patients with advanced solid tumours
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Phase I dose-escalation study ...... ts with advanced solid tumours
@ast
Phase I dose-escalation study ...... ts with advanced solid tumours
@en
type
label
Phase I dose-escalation study ...... ts with advanced solid tumours
@ast
Phase I dose-escalation study ...... ts with advanced solid tumours
@en
prefLabel
Phase I dose-escalation study ...... ts with advanced solid tumours
@ast
Phase I dose-escalation study ...... ts with advanced solid tumours
@en
P2093
P2860
P356
P1476
Phase I dose-escalation study ...... ts with advanced solid tumours
@en
P2093
C Falandry
K Soussan-Lazard
N Isambert
P Fumoleau
S Assadourian
S Ziti-Ljajic
P2860
P2888
P304
P356
10.1038/BJC.2012.304
P407
P577
2012-07-12T00:00:00Z